CANANDAIGUA, N.Y. — A judge in Ontario County ordered five of the seven people charged in the murder of a transgender man from Minnesota to turn over DNA. The defendants include Kyle Sage, Jennifer ...

The Dow Jones Industrial Average is declining Monday morning with shares of Merck and Sherwin-Williams Co. delivering the stiffest headwinds for the blue-chip average. Supported by world-class markets ...

A recent analysis indicated that switching from the standard-dose inactivated influenza vaccine to the recombinant influenza vaccine (RIV) could have prevented nearly 100,000 hospitalizations among ...

The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene ...

Credit: ImmunityBio. Developed by the Serum Institute of India, the rBCG product, which has been modified to improve its immunogenicity and safety, was evaluated in phase 1/2 clinical trials in Europe ...

Especially for therapies, hurdles remain. One is cost. Casgevy, the CRISPR cure for sickle-cell disease and beta-thalassemia, is expensive to make and to buy. Health-care systems in America and ...

Recombinant quadrivalent influenza vaccine (RIV4) and standard egg-based quadrivalent inactivated IV (IIV4) show comparable effectiveness in reducing influenza-related hospitalization among older ...

According to Coherent Market Insights, the global recombinant DNA technology market size is estimated to be valued at USD 172.94 billion in 2024 and is expected to surpass USD 327.63 billion by 2031, ...

If you use Microsoft PowerPoint, converting a PDF to into a PowerPoint is a great way to make complex documents more digestible for presentations. It doesn't have to be complicated, either. There are ...

The global recombinant DNA technology market was worth at approximately USD 803.76 billion in 2023 and is projected to grow USD 1,623.52 billion by 2034 from USD 856.81 billion in 2024, growing at a ...